US Nuclear Corp (UCLE)

US Nuclear Corp (OTC: UCLE) is a common stock listing on OTC Markets for US Nuclear Corp., a company that develops, manufactures, and sells radiation detection and measuring equipment worldwide. Through its Optron and Overhoff segments, the company provides a range of monitoring products, including radiation water monitors, alpha, beta, gamma, neutron, and tritium monitors, DroneRAD aerial detection systems, air and water monitors, nano-second X-ray monitors, vehicle and personnel monitors, radon products, handheld survey meters, dosimeters, pocket micro-R meters, and port security equipment. It also supplies software designed to track radiation levels and related environmental and facility conditions. US Nuclear Corp. serves customers in nuclear reactor plants, universities, hospitals, government agencies, emergency responders, airports, cargo and border screening operations, and other critical infrastructure settings. The company is headquartered in Canoga Park, California, and has a strategic alliance with Arbok-Nuclear focused on desalination and rad-wastewater treatment techniques.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-UCLE
$0.043
21.7% Upside
Undervalued
Fair
0.0%
-1.5x
-4.4x
1.0x
2.262 M
3.043 M
28.8%
75.7%
-20.3
-2.4%
13.5%
Valuation • Fair Value

US Nuclear Corp (OTC-UCLE) Fair Value by Valuation Model

Compare the primary fair value estimate for US Nuclear Corp (OTC-UCLE) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.043

Estimated upside of 21.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.037

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$0.053

Earnings power value estimate.

Comps Fair Value

$0.043

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for US Nuclear Corp (OTC-UCLE) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for US Nuclear Corp (OTC-UCLE)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.169 M

Current operating scale indicator.

Revenue Forecast

2.169 M

Forward revenue estimate.

EBITDA

-807.485 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review US Nuclear Corp (OTC-UCLE) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for US Nuclear Corp (OTC-UCLE)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-5.93

No elevated caution signal from this screen.

Altman Z-Score

-20.3

Lower score that deserves closer risk review.

FCF / Net Income

13.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for US Nuclear Corp (OTC-UCLE). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for US Nuclear Corp (OTC-UCLE)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

-2.4%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for US Nuclear Corp (OTC-UCLE), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

US Nuclear Corp (OTC-UCLE) Stock Forecast & Technical Outlook

Review US Nuclear Corp (OTC-UCLE) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for US Nuclear Corp (OTC-UCLE) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for US Nuclear Corp (OTC-UCLE) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for US Nuclear Corp (OTC-UCLE) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for US Nuclear Corp (OTC-UCLE) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for US Nuclear Corp (OTC-UCLE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for US Nuclear Corp (OTC-UCLE)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for US Nuclear Corp (OTC-UCLE) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

US Nuclear Corp (OTC-UCLE) Stock FAQ

Quick answers about US Nuclear Corp (OTC-UCLE) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.043
Estimated upside 21.7%
Valuation Rating
Undervalued
Estimated upside of 21.7%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for US Nuclear Corp (OTC-UCLE) is $0.043. This implies an estimated upside of 21.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 21.7% versus the current market price.

An analyst price target for US Nuclear Corp (OTC-UCLE) is not currently available in the latest data file.

The current financial health read for US Nuclear Corp (OTC-UCLE) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for US Nuclear Corp (OTC-UCLE) is -1.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for US Nuclear Corp is 2.262 M.

The current enterprise value listed for US Nuclear Corp is 3.043 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for US Nuclear Corp is OTC-UCLE, and the stock is listed on OTC Markets.

US Nuclear Corp (OTC-UCLE) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for US Nuclear Corp is 28.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for US Nuclear Corp is 75.7%. Free float helps investors understand how much of the share base is available for public trading.